Back to search results
Recruiting

Solid Tumor

A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors

JZCA | {{ defaultRegistry.registryAnchorText }} NCT03343613 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The purpose of this study is to evaluate the safety of the study drug LY3381916 administered alone or in combination with anti-programmed cell death ligand 1 (PD-L1) checkpoint antibody (LY3300054).

Time Commitment

Your participation in this trial could last up to 24 months, depending on your cancer type and how you and your tumor respond.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria

Gender

Male Female

Age

18+ years

-Participants must have a diagnosis of cancer (solid tumor) that has spread to other parts of the body

-Participants must be willing to provide required, newly acquired tumor biopsies (doctor removes a small amount of tissue)

-Participants must not have cancer that has spread to the brain

-Participants must not have an HIV infection or hepatitis B or C

-Participants must not have previously received an indoleamine- 2,3-dioxygenase (IDO) inhibitor

-Participants must not have an active autoimmune disease or currently require immunosuppression of >10 milligrams of prednisone or equivalent per day

-Participants must not have lung disease or inflammation of the lungs or a history of lung inflammation that required steroids

Where to Participate

Where to Participate

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.